국가: 미국
언어: 영어
출처: NLM (National Library of Medicine)
Mupirocin (UNII: D0GX863OA5) (Mupirocin - UNII:D0GX863OA5)
Taro Pharmaceuticals U.S.A., Inc.
TOPICAL
PRESCRIPTION
Mupirocin ointment is indicated for the topical treatment of canine bacterial infections of the skin, including superficial pyoderma, caused by susceptible strains of Staphylococcus aureus and Staphylococcus intermedius . This drug is contraindicated in animals with a history of sensitivity reactions to any of its components.
Mupirocin ointment is supplied in 5 g, 15 g, 22 g, and 30 g tubes. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Keep Out of Reach of Children
Abbreviated New Animal Drug Application
MUPIROCIN- MUPIROCIN OINTMENT TARO PHARMACEUTICALS U.S.A., INC. ---------- MUPIROCIN OINTMENT USP, 2% _For dermatologic use on dogs_ CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Each gram of mupirocin ointment contains 20 mg of mupirocin in a bland, water- washable ointment base consisting of polyethylene glycol 400 and polyethylene glycol 3350 (polyethylene glycol ointment). Mupirocin is a naturally-occurring, broad-spectrum antibiotic. The chemical name is 9-4-[5S-(2S,3S-epoxy-5S-hydroxy-4S-methylhexyl)- 3R,4R-dihydroxytetrahydropyran-2S-yl]-3-methylbut-2(E)-enoyloxy-nonanoic acid. The chemical structure is: CLINICAL PHARMACOLOGY Mupirocin is a chemical entity produced by fermentation of the organism _Pseudomonas_ _fluorescens_. Mupirocin inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl transfer-RNA synthetase. Due to this mode of action, mupirocin shows no cross resistance with chloramphenicol, erythromycin, gentamicin, lincomycin, neomycin, novobiocin, penicillin, streptomycin, and tetracycline. Mupirocin is an antimicrobial agent that inhibits the growth of gram-positive and gram-negative bacteria. Bacteria susceptible to the action of mupirocin _in vitro_ include the aerobic isolates of _Staphylococcus aureus_ (including methicillin-resistant strains and β-lactamase-producing strains), _Staphylococcus intermedius, Staphylococcus epidermidis_, other coagulase positive or negative Staphylococci, α-hemolytic Streptococci, β group A Streptococci (including _S. pyogenes)_, other β Streptococci (including _S. agalactiae)_, group D Streptococci (including _S. faecalis_ and _S. faecium)_, group Viridans Streptococci, _Streptococcus pneumoniae, Corynebacterium hofmanii, Bacillus subtilis, Escherichia coli,_ _Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae,_ _Enterobacter aerogenes, Citrobacter freundii, Hemophilus influenzae_ (including β- lactamase-producing strains), 전체 문서 읽기